The latest news on MS treatments, research and specialist services.
Keep up-to-date with interesting and relevant research articles relating to multiple sclerosis.
Features and blogs
MS Trust staff, health professionals and people with MS offer their perspectives on hot topics in the world of MS
Our free, quarterly newsletter for people with multiple sclerosis, their family and friends and supporters of the MS Trust.
Read our latest news
In a new blog, a person with MS chronicles her journey taking part in a clinical trial. This is part one in which Hellie spots a request for people to participate in a clinical trial.
Ian, diagnosed with primary progressive multiple sclerosis last August, tells us about his journey with MS and offers some advice for others in a similar situation.
The MS Trust is very disappointed that the Scottish Medicines Consortium is unable to recommend ocrelizumab as an NHS treatment for relapsing remitting MS.
- Ocrelizumab not approved for PPMS
- Solvents, smoking and MS risk
- Air pollutants not linked to MS
- Cannabis review finds benefits
Carole has been living with MS for 15 years. She tells us how channelling her creative side has helped her “see the good in things again”.
The combination of exposure to chemical solvents at work, having genes associated with MS and smoking greatly increases the risk of developing multiple sclerosis according to new research.
Paul Kosinski pushed himself out of his comfort zone to take part in our Jump in June skydiving month.
The MS Trust is very disappointed that NICE is unable to recommend ocrelizumab as an NHS treatment for early primary progressive MS.
- NICE say yes to Ocrevus for RRMS
- Review of medical cannabis
- PIP review changes
- Tysabri in SPMS
- Stress linked to MS risk
NICE has approved ocrelizumab (Ocrevus) as a treatment for relapsing remitting multiple sclerosis on the NHS in England and Wales.
Many people with MS experience 'cog fog', which is when you sometimes struggle with things like memory, attention span and concentration. In this blog, Helena, who was diagnosed with MS 11 years ago, talks about her own experience of the dreaded cog fog, and why she's determined those 'fuzzy brain days' won't stop her doing the things she loves.
On September 5, 2017, the MS Trust announced that it would be working with NHS Lanarkshire to improve access to MS nurses in the area, and ensure people living with MS get the support they need. Nine months on, we're pleased to report on the positive difference the new MS nurses have made to people with MS in Lanarkshire.
- School project explores MS
- Tecfidera and Gilenya compared
- Ocrevus delays progression
- Ocrevus in PPMS - new trial announced
- Obesity and smoking and risk of MS
- Family support helps
An MS diagnosis left Phil feeling ‘stunned and scared’, but writing about some of the emotions he experienced in a poem helped him come to terms with the diagnosis.
Jo Sopala, Director of Health Professional Programmes at the MS Trust, has signed up to run the British 10K in July and wants you to join her.
The weather's picked up, the BBQs are out and the ice-cream van is making its tuneful way up our road. This can only mean one thing: the holidays are hurtling towards us. As a general rule, breaks away are meant to be a relaxing experience. But when MS comes as part of the package deal, this isn't always the case. Caroline, who blogs at Mildly Scrambled, was diagnosed 14 years ago and has picked up a few holidaying tips along the way.
- NICE approves injectable drugs for relapsing MS
- Gilenya approved for young Americans
- AAN meeting round up
- RCN supports medical cannabis
- Vitamins and dietary supplements
We'd like to wish the best of luck to longstanding MS Trust supporter Jim Thompson as he begins a 1,300 mile trek.